Astrazeneca Vector Logo
AstraZeneca has a strong track record of innovation in the pharmaceutical industry. The company has developed a number of successful new therapies, including Tagrisso (osimertinib), a treatment for lung cancer, and Brilinta (ticagrelor), a treatment for acute coronary syndrome. AstraZeneca is also a leader in the development of vaccines, including Vaxzevria (AZD1222), a COVID-19 vaccine.
